Quick Answer
Fulgent Genetics, Inc. reported R&D Expense of $53.91 million for fiscal year 2025.
Fulgent Genetics, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $53.91M | +10.4% |
| 2024 | $48.82M | +17.8% |
| 2023 | $41.44M | +43.3% |
| 2022 | $28.91M | +19.4% |
| 2021 | $24.22M | +109.1% |
| 2020 | $11.58M | +77.1% |
| 2019 | $6.54M | +18.1% |
| 2018 | $5.53M | +31.0% |
| 2017 | $4.22M | +18.7% |
| 2016 | $3.56M | -19.7% |
| 2015 | $4.43M | +750.5% |
| 2014 | $521.0K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.86M | +17.6% | +2.8% |
| June 30, 2025 | $13.48M | -0.0% | +8.8% |
| March 31, 2025 | $12.39M | +8.4% | +5.2% |
| September 30, 2024 | $11.78M | +17.7% | -12.6% |
| June 30, 2024 | $13.49M | +39.1% | +17.9% |
| March 31, 2024 | $11.43M | +16.9% | +14.2% |
| September 30, 2023 | $10.01M | +33.4% | +3.3% |
| June 30, 2023 | $9.69M | +40.4% | -0.9% |
- Fulgent Genetics, Inc. showed an increase of +10.4% in R&D Expense compared to the prior fiscal year.
- Over the 2014–2025 period, Fulgent Genetics, Inc.’s r&d expense has grown by 10246.4% (from $521.0 thousand to $53.91 million).
- The most recent figure is from Fulgent Genetics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: